Historical

CLSI EP07-A2

Interference Testing in Clinical Chemistry; Approved Guideline - Second Edition

This document provides background information, guidance, and experimental procedures for investigating, identifying, and characterizing the effects of interfering substances on clinical chemistry test results. The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement

CONTENT PROVIDER
Clinical And Laboratory Standards Institute [clsi]

Others Also Bought
Diagnostic Reagents; Approved Guideline Stability of In Vitro Diagnostic Reagents; Approved Guideline
Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline - Third Edition
Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline -Second Edition ...
Included in Packages
This standard is not included in any packages.
Document History
Revised By:
Amendments & Corrections
We have no amendments or corrections for this standard.